Skip to main content

LGI1-Antibody Encephalitis clinical trials at UCSF

1 research study open to eligible people

LGI1-antibody encephalitis is a brain disorder caused by the immune system attacking healthy cells. UCSF is testing a drug called Satralizumab to see if it helps people with this condition. The study also checks how safe the drug is and how it works in the body.

Showing trials for

Last updated: